Cargando…
Population Pharmacodynamic Analyses of Human Anti-Rabies Virus Monoclonal Antibody (Ormutivimab) in Healthy Adult Subjects
Ormutivimab is the first recombinant human anti-rabies monoclonal antibody (rhRIG) approved for clinical application in China. In this study, a population pharmacodynamic (PPD) model was established to compare the neutralizing antibody activities of Ormutivimab and human rabies immunoglobulin (HRIG)...
Autores principales: | Zhang, Junnan, Shi, Nianmin, Li, Guohua, Li, Li, Bai, Yunhua, Yang, Liqing, Zhao, Weimin, Gao, Jian, Wei, Jingshuang, Zhao, Wei, Zhai, Lili, Huo, Peiyuan, Ren, Lemin, Yu, Lan, Li, Yufeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415024/ https://www.ncbi.nlm.nih.gov/pubmed/36016106 http://dx.doi.org/10.3390/vaccines10081218 |
Ejemplares similares
-
Advances in the progress of monoclonal antibodies for rabies
por: Fan, Linlin, et al.
Publicado: (2022) -
Safety and Viral Shedding of Live Attenuated Influenza Vaccine (LAIV) in Chinese Healthy Juveniles and Adults: A Phase Ⅰ Randomized, Double-Blind, Placebo-Controlled Study
por: Li, Li, et al.
Publicado: (2022) -
Preparation and identification of anti-rabies virus monoclonal antibodies
por: Wang, Wen-juan, et al.
Publicado: (2012) -
Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposure
por: Kang, Gagandeep, et al.
Publicado: (2023) -
Characterization and potential diagnostic application of monoclonal antibodies specific to rabies virus()
por: Liu, Xinjian, et al.
Publicado: (2010)